Drug Chatter -- Tracking biopharma stock chatter

Profile for Galmed Pharmaceuticals Ltd. (GLMD)

« Back to company index

GLMD Chatter Timeline

Stock Ticker for GLMD

Most Active Tweeters for GLMD

UserTweets
@AmericanBanking 13
@ConsumerFeed 10
@CFinancialNews 8
@intercooleronli 8
@IRAMarketReport 7

Recent Tweets for GLMD

SleekMoneycom @SleekMoneycom
Brokerages Anticipate Galmed Pharmaceuticals Ltd. $GLMD to Post -$0.26 Earnings Per Share https://t.co/rvOIPKLwUY
November 19th 2017, 11:11am
ConsumerFeed @ConsumerFeed
Galmed Pharmaceuticals Ltd. $GLMD Downgraded to “Hold” at Zacks Investment Research https://t.co/sfaD4ijRQD
November 19th 2017, 10:11am
dakotafinancial @dakotafinancial
Galmed Pharmaceuticals Ltd. $GLMD Downgraded to “Hold” at Zacks Investment Research https://t.co/AqhAZqdzvY
November 19th 2017, 10:11am
VWatchers @VWatchers
https://t.co/F9qTTgEqhX - Galmed Pharmaceuticals Ltd. ( $GLMD ) #stockstobuy
November 19th 2017, 12:11am
storminvestor @storminvestor
Galmed Pharmaceuticals Ltd. $GLMD Downgraded by Zacks Investment Research https://t.co/y4Gllxxtni
November 18th 2017, 3:11pm
ConsumerFeed @ConsumerFeed
Galmed Pharmaceuticals Ltd. $GLMD Upgraded to Buy at Zacks Investment Research https://t.co/P5k8aWy0UT
November 18th 2017, 2:11pm
dakotafinancial @dakotafinancial
Galmed Pharmaceuticals Ltd. $GLMD Upgraded to Buy at Zacks Investment Research https://t.co/56h7VYTKMn
November 18th 2017, 2:11pm
stocknewstimes @stocknewstimes
Maxim Group Reiterates “Buy” Rating for Galmed Pharmaceuticals Ltd. $GLMD https://t.co/DIkLHKqhY0
November 18th 2017, 11:11am
midetimes @midetimes
Galmed Pharmaceuticals Ltd. $GLMD Lifted to “Buy” at Zacks Investment Research https://t.co/nFY495R810
November 17th 2017, 8:11pm
WKRBNews @WKRBNews
Galmed Pharmaceuticals Ltd. $GLMD Lifted to “Buy” at Zacks Investment Research https://t.co/HoeHgy89d7
November 17th 2017, 8:11pm
dailymailtimes @dailymailtimes
Galmed Pharmaceuticals Ltd. $GLMD Lifted to “Buy” at Zacks Investment Research https://t.co/fOvm6bw7Pi
November 17th 2017, 8:11pm
dailypoliticaln @dailypoliticaln
Galmed Pharmaceuticals Ltd. $GLMD Lifted to “Buy” at Zacks Investment Research https://t.co/zNGdJ6T7vz
November 17th 2017, 8:11pm
chaffeybreeze @chaffeybreeze
Galmed Pharmaceuticals Ltd. $GLMD Coverage Initiated at Roth Capital https://t.co/DYAQTZI3kB
November 17th 2017, 5:11pm
IRAMarketReport @IRAMarketReport
Galmed Pharmaceuticals Ltd. $GLMD Coverage Initiated at Roth Capital https://t.co/3WwCcoTORu
November 17th 2017, 5:11pm
danrocks4 @danrocks4
GLMD is number 87 for the largest percentage gain out of 100 stocks. $GLMD Galmed Pharmaceutica is up +15.04% https://t.co/u5rhTChroi
November 17th 2017, 12:11pm
ZolmaxNews @ZolmaxNews
Galmed Pharmaceuticals Ltd. $GLMD Stock Rating Lowered by Zacks Investment Research https://t.co/bfh2HmmUHa
November 17th 2017, 8:11am
ZolmaxNews @ZolmaxNews
$GLMD - Galmed Pharmaceuticals Ltd. #GLMD Stock Rating Lowered by Zacks Investment Research https://t.co/Obiu5jsAoU
November 17th 2017, 7:11am
dispatchtribune @dispatchtribune
Galmed Pharmaceuticals Ltd. $GLMD Now Covered by Analysts at Roth Capital https://t.co/rGD2B8z5bu
November 16th 2017, 8:11pm
dispatchtribune @dispatchtribune
Galmed Pharmaceuticals Ltd. $GLMD Expected to Announce Earnings of -$0.27 Per Share https://t.co/thFEtHglMm
November 16th 2017, 7:11pm
chaffeybreeze @chaffeybreeze
Galmed Pharmaceuticals Ltd. $GLMD Downgraded to “Hold” at Zacks Investment Research https://t.co/VmPKo9qVNK
November 16th 2017, 3:11pm
WeekHerald @WeekHerald
Galmed Pharmaceuticals Ltd. $GLMD Downgraded to “Hold” at Zacks Investment Research https://t.co/grutZloMQK
November 16th 2017, 3:11pm
IRAMarketReport @IRAMarketReport
Galmed Pharmaceuticals Ltd. $GLMD Downgraded to “Hold” at Zacks Investment Research https://t.co/b4NQLYRjru
November 16th 2017, 3:11pm
ZolmaxNews @ZolmaxNews
Galmed Pharmaceuticals Ltd. Forecasted to Earn Q4 2017 Earnings of -$0.23 Per Share $GLMD https://t.co/lVaw1QT8ec
November 16th 2017, 10:11am
WeekHerald @WeekHerald
Zacks Investment Research Upgrades Galmed Pharmaceuticals Ltd. $GLMD to “Buy” https://t.co/UHE1xo0kkD
November 16th 2017, 7:11am
AmericanBanking @AmericanBanking
Galmed Pharmaceuticals Ltd. $GLMD Cut to “Hold” at Zacks Investment Research https://t.co/thr99GMvkT
November 16th 2017, 12:11am
intercooleronli @intercooleronli
Galmed Pharmaceuticals Ltd. $GLMD Cut to “Hold” at Zacks Investment Research https://t.co/0J1bh5uK54
November 16th 2017, 12:11am
CFinancialNews @CFinancialNews
Galmed Pharmaceuticals Ltd. $GLMD Cut to “Hold” at Zacks Investment Research https://t.co/4Yt8hTetU4
November 16th 2017, 12:11am
ConsumerFeed @ConsumerFeed
Galmed Pharmaceuticals Ltd. $GLMD Cut to “Hold” at Zacks Investment Research https://t.co/R9BwiskpwD #acn
November 16th 2017, 12:11am
RatingsNetwork @RatingsNetwork
Galmed Pharmaceuticals downgraded by Zacks Investment Research to hold. https://t.co/fSSsCQgR4B $GLMD #GLMD
November 16th 2017, 12:11am
AmericanBanking @AmericanBanking
Galmed Pharmaceuticals downgraded by Zacks Investment Research to hold. https://t.co/T9ohLMfGT9 $GLMD #GLMD
November 16th 2017, 12:11am
ConsumerFeed @ConsumerFeed
Galmed Pharmaceuticals downgraded by Zacks Investment Research to hold. https://t.co/xUIiac3gZG $GLMD #GLMD
November 16th 2017, 12:11am
realmaciej @realmaciej
RT @juliustrades: Roth initiating $GLMD with a Buy rating and a 12-month price target of $32/share based on confidence in the clinical succ…
November 15th 2017, 9:11pm
ZolmaxNews @ZolmaxNews
Galmed Pharmaceuticals Ltd. $GLMD Upgraded by Zacks Investment Research to “Buy” https://t.co/mrehXrNjNW
November 15th 2017, 6:11pm
surveyist @surveyist
RT @jfais20: #ROTY holding $GLMD initiated at Roth$32 PT, confidence in clinical success in #NASH / fatty liver disease
November 15th 2017, 6:11pm
jfais20 @jfais20
#ROTY holding $GLMD initiated at Roth$32 PT, confidence in clinical success in #NASH / fatty liver disease
November 15th 2017, 1:11pm
AmericanBanking @AmericanBanking
Galmed Pharmaceuticals Ltd. $GLMD Given Average Recommendation of “Buy” by Analysts https://t.co/c2tylx3lDS
November 15th 2017, 12:11pm
TickerReport @TickerReport
Galmed Pharmaceuticals Ltd. $GLMD Given Average Recommendation of “Buy” by Analysts https://t.co/26pgLb7CvQ
November 15th 2017, 12:11pm
emq_news @emq_news
Galmed Pharmaceuticals Ltd. $GLMD Given Average Recommendation of “Buy” by Analysts https://t.co/soLDWGTpo0
November 15th 2017, 12:11pm
intercooleronli @intercooleronli
Galmed Pharmaceuticals Ltd. $GLMD Given Average Recommendation of “Buy” by Analysts https://t.co/iuyW73h6WU
November 15th 2017, 12:11pm
TickerReport @TickerReport
Galmed Pharmaceuticals Ltd. $GLMD Given Average Recommendation of “Buy” by Analysts https://t.co/BXolzJw9Ly
November 15th 2017, 12:11pm
CFinancialNews @CFinancialNews
Galmed Pharmaceuticals Ltd. $GLMD Given Average Recommendation of “Buy” by Analysts https://t.co/xY3BOCYNpm
November 15th 2017, 12:11pm
stocknewstimes @stocknewstimes
Galmed Pharmaceuticals Ltd. $GLMD Given Average Recommendation of “Buy” by Analysts https://t.co/Q6HM79M7p8
November 15th 2017, 12:11pm
intercooleronli @intercooleronli
Galmed Pharmaceuticals Ltd. $GLMD Research Coverage Started at Roth Capital https://t.co/IVt6i1t6NK
November 15th 2017, 11:11am
AmericanBanking @AmericanBanking
Galmed Pharmaceuticals Ltd. $GLMD Research Coverage Started at Roth Capital https://t.co/aGo40qODMG
November 15th 2017, 11:11am
CFinancialNews @CFinancialNews
Galmed Pharmaceuticals Ltd. $GLMD Research Coverage Started at Roth Capital https://t.co/14Fqxr9Nl8
November 15th 2017, 11:11am
AmericanBanking @AmericanBanking
Galmed Pharmaceuticals Gets Average Rating of Buy from Analysts $GLMD https://t.co/74vj0RXRbL
November 15th 2017, 11:11am
SleekMoneycom @SleekMoneycom
Galmed Pharmaceuticals Ltd. $GLMD Now Covered by Roth Capital https://t.co/FtyWUf70Zq
November 15th 2017, 10:11am
ConsumerFeed @ConsumerFeed
Galmed Pharmaceuticals initiated by Roth Capital at buy. $32.00 PT. https://t.co/DJ9bqwPcp6 $GLMD #GLMD
November 15th 2017, 10:11am
RatingsNetwork @RatingsNetwork
Galmed Pharmaceuticals initiated by Roth Capital at buy. $32.00 PT. https://t.co/fl6MwtBOFe $GLMD #GLMD
November 15th 2017, 10:11am
AmericanBanking @AmericanBanking
Galmed Pharmaceuticals initiated by Roth Capital at buy. $32.00 PT. https://t.co/6QgNZNmJSo $GLMD #GLMD
November 15th 2017, 10:11am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.